For your information this abstract:
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
http://www.ncbi.nlm.nih.gov/pubmed/20042414
I have not investigated this option or asked an oncologist for an opinion on this experimental treatment.
The previous report on this treatment in 2006:
http://www.ncbi.nlm.nih.gov/pubmed/16484716